CFG Wealth Management Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10
Closed -$1.97K 92
2026
Q1
$1.97K Hold
10
﹤0.01% 148
2025
Q4
$1.84K Buy
+10
New +$1.75K ﹤0.01% 154

Other funds holding AZN

CFG Wealth Management Services's AZN Position: Q2 2026 in Review

CFG Wealth Management Services sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 10 shares — an estimated $1.97K sold.

CFG Wealth Management Services first reported a position in AZN in Q4 2025 and held it in 2 quarters. The position peaked at $1.97K in Q1 2026. 1,493 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • CFG Wealth Management Services reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • CFG Wealth Management Services sold 10 AstraZeneca shares in Q2 2026, an estimated $1.97K.
  • CFG Wealth Management Services first reported a position in AstraZeneca in Q4 2025 and held it in 2 quarters.
  • CFG Wealth Management Services's AstraZeneca position peaked at $1.97K in Q1 2026.
  • 1,493 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CFG Wealth Management Services's 13F filing for Q2 2026, filed 15 Jul 2026.